William Orr to Dose-Response Relationship, Drug
This is a "connection" page, showing publications William Orr has written about Dose-Response Relationship, Drug.
Connection Strength
0.161
-
Effects of mosapride on esophageal secondary peristalsis in humans. Neurogastroenterol Motil. 2011 Jul; 23(7):606-e249.
Score: 0.084
-
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study. Neurogastroenterol Motil. 2014 Jan; 26(1):13-20.
Score: 0.025
-
Dose--response effect of famotidine on patterns of gastro-oesophageal reflux. Aliment Pharmacol Ther. 1988 Jun; 2(3):229-35.
Score: 0.017
-
Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2002 Jun; 97(6):1332-9.
Score: 0.011
-
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002 Apr; 16(4):749-57.
Score: 0.011
-
Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux. Aliment Pharmacol Ther. 1991 Dec; 5(6):621-30.
Score: 0.005
-
Dose-related effects of phenobarbitone on human sleep-waking patterns. Br J Clin Pharmacol. 1981 Sep; 12(3):303-13.
Score: 0.003
-
Dose-related effects of flurazepam on human sleep-walking patterns. Psychopharmacology (Berl). 1981; 73(4):332-9.
Score: 0.003
-
Induction of acute inflammatory reactions in lung following intrapulmonary instillation of preformed chemotactic peptides and purified complement components. Chest. 1979 Feb; 75(2 Suppl):259-62.
Score: 0.002